[
  {
    "ts": "2025-12-09T11:30:00+00:00",
    "headline": "Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the expanded launch and first shipment of its next-generation Leo™ System, powered by Simple Western™ Technology.",
    "url": "https://finance.yahoo.com/news/bio-techne-launches-enhanced-leo-113000886.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b617ba7c-21a6-3af2-a0fb-85d857170f68",
      "content": {
        "id": "b617ba7c-21a6-3af2-a0fb-85d857170f68",
        "contentType": "STORY",
        "title": "Bio-Techne Launches the Enhanced Leo™ System Delivering Advanced Multiplexing and High-Throughput Protein Analysis",
        "description": "",
        "summary": "Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents, and diagnostic products, today announced the expanded launch and first shipment of its next-generation Leo™ System, powered by Simple Western™ Technology.",
        "pubDate": "2025-12-09T11:30:00Z",
        "displayTime": "2025-12-09T11:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/2f1fccae71e1ce5bc244dd0b67aaa0ee",
          "originalWidth": 400,
          "originalHeight": 100,
          "caption": "Bio-Techne Logo (PRNewsfoto/Bio-Techne Corporation)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.8zSeupOxYHJ3tgWToHHag--~B/aD0xMDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2f1fccae71e1ce5bc244dd0b67aaa0ee.cf.webp",
              "width": 400,
              "height": 100,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ichXDlmjjJHZF.zDxLgbeg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/2f1fccae71e1ce5bc244dd0b67aaa0ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-launches-enhanced-leo-113000886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-launches-enhanced-leo-113000886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-09T21:12:29+00:00",
    "headline": "Does Bio-Techne’s Recent Weakness Offer an Opportunity After Its Cell and Gene Therapy Push?",
    "summary": "Wondering if Bio-Techne at around $60 a share is a bargain in disguise or a value trap? This breakdown will walk you through what the numbers are really saying about the stock. Despite being down about 21.7% over the last year and 15.7% year to date, the stock has shown some near term resilience with a 5.0% gain over the past month, even after slipping 5.4% in the last week. Recent headlines have focused on Bio-Techne expanding its portfolio of life science tools and strengthening...",
    "url": "https://finance.yahoo.com/news/does-bio-techne-recent-weakness-211229866.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ba6dea95-d5e8-371b-a6e1-7b9cb876ff4a",
      "content": {
        "id": "ba6dea95-d5e8-371b-a6e1-7b9cb876ff4a",
        "contentType": "STORY",
        "title": "Does Bio-Techne’s Recent Weakness Offer an Opportunity After Its Cell and Gene Therapy Push?",
        "description": "",
        "summary": "Wondering if Bio-Techne at around $60 a share is a bargain in disguise or a value trap? This breakdown will walk you through what the numbers are really saying about the stock. Despite being down about 21.7% over the last year and 15.7% year to date, the stock has shown some near term resilience with a 5.0% gain over the past month, even after slipping 5.4% in the last week. Recent headlines have focused on Bio-Techne expanding its portfolio of life science tools and strengthening...",
        "pubDate": "2025-12-09T21:12:29Z",
        "displayTime": "2025-12-09T21:12:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0Ih9Jyeb4E8RAOq22ZtFHA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5jgPUxQrxmcesBmGBKgkQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/2319011507a24b47a4bb11db126344d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/does-bio-techne-recent-weakness-211229866.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/does-bio-techne-recent-weakness-211229866.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TECH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]